中国城市成人髋部骨折发病率及趋势:全国回顾性队列研究
BACKGROUND: Hip fracture is a public health concern because of its considerable morbidity, excess mortality, great risk of disability, and high societal healthcare costs.…
要点
- 2012–2016年中国55岁及以上人群髋部骨折总体发病率未上升,呈平台期。
- 65岁及以上人群发病率下降,较年轻患者相对稳定。
核心结论
- 研究期间中国55岁及以上人群髋部骨折发病率达到平台期,但绝对例数与住院医疗费用因人口老龄化快速增加。
研究设计与样本
- 基于中国城镇职工与城镇居民基本医疗保险全国数据库的基于人群的回顾性队列研究,数据年份为2012至2016年。
- 共识别190,560例新发髋部骨折患者,平均年龄77.05岁(标准差8.94),女性占63.99%。
主要发现
- 女性髋部骨折发病率2012年为每10万人年180.72(95%CI 137.16, 224.28;P < 0.001),2016年为177.13(95%CI 139.93, 214.33;P < 0.001)。
- 男性髋部骨折发病率2012年为每10万人年121.86(95%CI 97.30, 146.42;P < 0.001),2016年为99.15(95%CI 81.31, 116.99;P < 0.001)。
- 两性65岁及以上患者髋部骨折发病率均下降,较年轻患者发病率相对稳定。
- 55岁及以上人群髋部骨折绝对数量研究期间增加约4倍。
关键数值与推荐
- 每例患者住院费用由2012年4,300美元升至2016年6,840美元,增加约1.59倍。
临床怎么用
- 提示应针对老龄化背景下髋部骨折绝对例数与住院费用快速上升配置防治与医疗资源。
局限性
- 主要局限性为缺乏影像学信息以判定髋部骨折病例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hip fracture is a public health concern because of its considerable morbidity, excess mortality, great risk of disability, and high societal healthcare costs. China has the largest population of older people in the world and is experiencing rapid population aging and facing great challenges from an increasing number of hip fractures. However, few studies reported the epidemiology, especially at a national level. We aimed to evaluate trends in hip fracture incidence and associated costs for hospitalization in China. METHODS AND FINDINGS: We conducted a population-based study using data between 2012 and 2016 from the national databases of Urban Employee Basic Medical Insurance and Urban Resident Basic Medical Insurance in China, covering about 480 million residents. Data from around 102.56 million participants aged 55 years and older during the study period were analyzed. A total of 190,560 incident hip fracture patients (mean age 77.05 years, standard deviation 8.94; 63.99% female) were identified. Primary outcomes included the age- and sex-specific incidences of hip fracture. Associated annual costs for hospitalization were also calculated. Incidence was described as per 100,000 person-years at risk, and 95% confidence intervals were computed assuming a Poisson distribution. Hip fracture incidence overall in China did not increase during the study period despite rapid population aging. Incidence per 100,000 was 180.72 (95% CI 137.16, 224.28; P < 0.001) in 2012 and 177.13 (95% CI 139.93, 214.33; P < 0.001) in 2016 for females, and 121.86 (95% CI 97.30, 146.42; P < 0.001) in 2012 and 99.15 (95% CI 81.31, 116.99; P < 0.001) in 2016 for males. For both sexes, declines in hip fracture incidence were observed in patients aged 65 years and older, although incidence was relatively stable in younger patients. However, the total absolute number of hip fractures in those 55 years and older increased about 4-fold. The total costs for hospitalization showed a steep rise from US$60 million to US$380 million over the study period. Costs for hospitalization per patient increased about 1.59-fold, from US$4,300 in 2012 to US$6,840 in 2016. The main limitation of the study was the unavailability of data on imaging information to adjudicate cases of hip fracture. CONCLUSIONS: Our results show that hip fracture incidence among patients aged 55 and over in China reached a plateau between 2012 and 2016. However, the absolute number of hip fractures and associated medical costs for hospitalization increased rapidly because of population aging.
引用
- Zhang C, Feng J, Wang S, et al. Incidence of and trends in hip fracture among adults in urban China: A nationwide retrospective cohort study. PLoS Med. 2020. PMID: 32760065. doi:10.1371/journal.pmed.1003180
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。